Enable AccessibilityEnable Accessibility

Quarterly Results FY2022 (April 2022-March 2023)

Earnings announcement for FY2022 (May 11, 2023)

Webcast for Investors, Analysts and Media, 7:00pm-8:30pm JST (Presentation and Q&A Session)

Participants:

  • Christophe Weber, President and Chief Executive Officer
  • Costa Saroukos, Chief Financial Officer
  • Andy Plump, President, Research & Development and others


Document Q1 Q2 Q3 Q4
Financial Statements (Tokyo Stock Exchange filling) PDF_file_icon.svg.png PDF_file_icon.svg.png PDF_file_icon.svg.png PDF_file_icon.svg.png

Quarterly Financial Report

 PDF_file_icon.svg.png PDF_file_icon.svg.png PDF_file_icon.svg.png PDF_file_icon.svg.png

Excel version of selected tables from the Quarterly Financial Report

 Microsoft_Office_Excel_(2019–present).svg.png Microsoft_Office_Excel_(2019–present).svg.png Microsoft_Office_Excel_(2019–present).svg.png Microsoft_Office_Excel_(2019–present).svg.png

Presentation

 PDF_file_icon.svg.png PDF_file_icon.svg.png PDF_file_icon.svg.png PDF_file_icon.svg.png
Webcast

microphone.png

microphone.png

microphone.png

microphone.png

Clinical trial summary (updated May 11, 2023) pdf2.png

Epidemiology data (updated May 11, 2023) pdf2.png

Financial Results Archive




Topics

Newsroom
LEARN MORE

Featured Topics
LEARN MORE

In the News
LEARN MORE
Copyright 1995-2023 Takeda Pharmaceutical Company Limited. All rights reserved.